Promoting analysis of real-world data: Prospects for preventive cardiology in Japan

Haruki Yotsumoto1, Hidehiro Kaneko1,2, Hidetaka Itoh1

  • 1Department of Cardiovascular Medicine, The University of Tokyo, Tokyo, Japan.

Global Health & Medicine
|September 17, 2021
PubMed

Insights

Cardiovascular and cerebrovascular diseases are leading causes of death in Japan. Analyzing health checkup data can advance preventive cardiology and public health.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Cardiovascular and cerebrovascular diseases are leading causes of death in Japan, accounting for 23.2% of all deaths in 2018.
  • While mortality from cerebral hemorrhage has decreased due to hypertension management, lifestyle-related diseases like metabolic syndrome and ischemic heart disease are increasing.
  • Aging populations will inevitably increase the future incidence of heart failure in Japan.

Purpose of the Study:

  • To highlight the significance of preventive cardiology in light of rising lifestyle-related diseases and an aging population.
  • To emphasize the value of analyzing real-world data from Japanese health checkups for clinical research and public health.
  • To advocate for the dissemination of findings from health checkup data analysis into clinical practice.

Main Methods:

  • Utilizing big data from physical examinations and specific health checkups (metabolic syndrome checkups) conducted in Japan since 2008.
  • Analyzing real-world data to identify trends and risk factors associated with cardiovascular and cerebrovascular diseases.
  • Leveraging existing evidence on the effectiveness of risk factor prevention and management.

Main Results:

  • Cardiovascular disease caused 208,210 deaths and cerebrovascular disease caused 108,165 deaths in Japan in 2018.
  • Mortality rates for cerebral hemorrhage have significantly declined from historical highs.
  • There is a concerning rise in mortality from lifestyle-related diseases, necessitating a focus on preventive strategies.

Conclusions:

  • Preventive cardiology is crucial for mitigating the future incidence of cardiovascular disease.
  • Real-world data from Japanese health checkups represent a valuable resource for clinical research.
  • Disseminating findings from health checkup data analysis into clinical practice will promote public health and advance preventive cardiology.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
401
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
504
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
423
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
90
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
265
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
62